agilon health (NYSE:AGL) Trading 8.5% Higher on Analyst Upgrade

agilon health, inc. (NYSE:AGL - Get Free Report)'s stock price shot up 8.5% during trading on Thursday after Sanford C. Bernstein raised their price target on the stock from $2.50 to $3.15. Sanford C. Bernstein currently has a market perform rating on the stock. agilon health traded as high as $3.07 and last traded at $3.06. 2,185,717 shares changed hands during mid-day trading, a decline of 49% from the average session volume of 4,326,648 shares. The stock had previously closed at $2.82.

Other research analysts have also recently issued reports about the stock. William Blair cut shares of agilon health from an "outperform" rating to a "market perform" rating in a research report on Friday, November 8th. Citigroup upgraded shares of agilon health from a "sell" rating to a "neutral" rating and lifted their target price for the company from $1.75 to $2.25 in a report on Friday, January 10th. Stifel Nicolaus cut their price target on agilon health from $7.00 to $2.00 and set a "hold" rating on the stock in a research note on Tuesday, November 12th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $3.00 price objective on shares of agilon health in a research report on Tuesday, November 19th. Finally, Barclays dropped their target price on agilon health from $5.00 to $2.00 and set an "underweight" rating on the stock in a report on Monday, November 11th. Two research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $4.03.

Insider Activity

In other news, Director Karen Mcloughlin bought 25,000 shares of the stock in a transaction that occurred on Friday, December 13th. The shares were bought at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the purchase, the director now owns 73,166 shares in the company, valued at $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director John William Wulf bought 45,000 shares of the company's stock in a transaction that occurred on Thursday, December 5th. The stock was purchased at an average cost of $2.18 per share, with a total value of $98,100.00. Following the acquisition, the director now directly owns 206,133 shares in the company, valued at $449,369.94. This trade represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 90,000 shares of company stock valued at $198,100 in the last ninety days. Corporate insiders own 3.20% of the company's stock.

Hedge Funds Weigh In On agilon health

A number of hedge funds have recently made changes to their positions in the business. State Street Corp lifted its holdings in agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company's stock worth $29,277,000 after purchasing an additional 215,733 shares in the last quarter. Geode Capital Management LLC grew its holdings in agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company's stock valued at $27,097,000 after buying an additional 84,889 shares in the last quarter. Citigroup Inc. raised its position in shares of agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company's stock valued at $7,971,000 after buying an additional 1,941,993 shares during the last quarter. JPMorgan Chase & Co. grew its stake in agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock valued at $5,563,000 after acquiring an additional 1,083,492 shares in the last quarter. Finally, AQR Capital Management LLC lifted its stake in agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company's stock worth $8,871,000 after purchasing an additional 1,316,990 shares in the last quarter.

agilon health Price Performance

The firm has a market cap of $1.28 billion, a P/E ratio of -3.31 and a beta of 0.53. The firm's fifty day simple moving average is $2.07 and its 200 day simple moving average is $3.67. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The firm had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. During the same period in the previous year, the company posted ($0.06) earnings per share. As a group, analysts forecast that agilon health, inc. will post -0.59 earnings per share for the current year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.